TLPH Q3 2023 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q3 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$117,000

Gross Profit

-$1M-906.8% margin

Operating Income

-$3M-2828.2% margin

Net Income

-$1M-1159.8% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-53.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$23M

Total Liabilities

$5M

Stockholders' Equity

$18M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$117,000	$0	—
Gross Profit	-$1M	-$424,000	-150.2%
Operating Income	-$3M	-$5M	+26.8%
Net Income	-$1M	-$7M	+79.9%